USA News Group News Commentary – According to the American Cancer Society, 2024 will be the first year the USA expects to have more than 2 million new cancer cases. In order to respond to the rising...
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GOVX),(NYSE:GSK),(NASDAQ:AZN),(NYSE:MRK) EQNX::TICKER_END
The Food and Drug Administration recently approved a new vaccine from Moderna, but the stock dipped in response.
Earnings season is slowing down, but we still have a few big names reporting. This week, we have Alibaba, Home Depot, Walmart, Cisco and Deere & Company all reporting.
The Federal Trade Commission is challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic
Wall Street analysts who watch the cancer drug developer closely think it could rocket higher.
These stocks could rocket higher, but they also present significant risks.
Several well-regarded funds run by famous billionaire investors bought shares of 23andMe during the last three months of 2023.
/CNW/ - Find Therapeutics Inc., a biopharmaceutical company focused on the development of innovative therapies for autoimmune diseases, today announced that...